Study programme 2017-2018 | Français | ||
Pharmaceutical Chemistry: Organic Drug Studies - Part 1 | |||
Programme component of Bachelor's Degree in Pharmacy à la Faculty of Medicine and Pharmacy |
Code | Type | Head of UE | Department’s contact details | Teacher(s) |
---|---|---|---|---|
UM-B3-PHARMA-002-M | Compulsory UE | DUFRASNE François | M136 - Chimie thérapeutique et Pharmacognosie |
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
---|---|---|---|---|---|---|---|---|---|
| Français | 47 | 75 | 0 | 0 | 0 | 9 | 9 | 1st term |
AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
---|---|---|---|---|---|---|---|---|
M-CTPH-301 | Pharmacochemistry - part 1 | 47 | 75 | 0 | 0 | 0 | Q1 | 100.00% |
Programme component | ||
---|---|---|
UM-B2-PHARMA-003-M Organic Chemistry I | ||
UM-B3-PHARMA-004-M Inorganic Drugs | ||
UM-B2-PHARMA-004-M Organic Chemistry II |
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
The student must be able to learn several aspects of the drugs used in Belgium, among which their pharmacological and physico-chemical properties, their pratical uses in medicine, how to analyse them and how to create new drugs.
Content of UE
* Theory: analysis of chemical groups; drug design at the molecular level (molecular pharmacochemistry); systematic study of several pharmaceutical classes (anti-infectious drugs, antitumoral and immunomodulatory drugs; peripheral nervous system drugs). * Laboratory work: analysis of several samples of drugs (with our without impurities) following a European Pharmacopoeia monograph (identity, purity and assay).
Prior Experience
Prerequisites : Chimie organique. Pharmacologie générale. Courses to be followed along with the present UE : Chimie analytique qualitative et quantitative Analyse instrumentale pharmaceutique Etude des médicaments inorganiques Pharmacognosie: Phytochimie et étude des médicaments d'origine végétale Pharmacologie générale
Type of Assessment for UE in Q1
Q1 UE Assessment Comments
Final mark : 2/3 for the theoretical examination and 1/3 for the practical work (within this last section : the mean of the practical work contributes for 2/3 of the final mark and the practical work written examination for 1/3). However, if the theoretical examination is not successful (score strictly less than 10/20), only the theoretical mark is taken into account. <strong><u>Warnings regarding the written examination</u></strong>: - Each question is scored on 0.5, 1 or 2 depending on the expected level of response. The intermediate mark is calculated from the total marks for the entire examination and then recalculated to 20 for the final mark. - depending on the quality of <strong>incorrect response given</strong> (eg, errors considered <u>serious</u> in terms of the importance of the covered concepts or their fundamental aspect regarding the level of study) or the <strong>quality of expression answers</strong> (eg, <u>globaly</u> for the examination: poorly organized answers, not correctly written, or nebulous meaning), <strong>additional points may be withdrawn without exceeding 2/20 on the final mark.</strong>
Type of Assessment for UE in Q3
Q3 UE Assessment Comments
- There is no practical examination in Q3 but a possibility to present once again the theoretical examination related to practical work. - Final mark : 2/3 for the theoretical examination and 1/3 for the practical work (within this last section : the mean of the practical work contributes for 2/3 of the final mark and the practical work written examination for 1/3). However, if the theoretical examination is not successful (score strictly less than 10/20), only the theoretical mark is taken into account. <strong><u>Warnings regarding the written examination</u></strong>: - Each question is scored on 0.5, 1 or 2 depending on the expected level of response. The intermediate mark is calculated from the total marks for the entire examination and then recalculated to 20 for the final mark. - depending on the quality of <strong>incorrect response given</strong> (eg, errors considered <u>serious</u> in terms of the importance of the covered concepts or their fundamental aspect regarding the level of study) or the <strong>quality of expression answers</strong> (eg, <u>globaly</u> for the examination: poorly organized answers, not correctly written, or nebulous meaning), <strong>additional points may be withdrawn without exceeding 2/20 on the final mark.</strong>
Type of Resit Assessment for UE in Q1 (BAB1)
Q1 UE Resit Assessment Comments (BAB1)
Not applicable
Type of Teaching Activity/Activities
AA | Type of Teaching Activity/Activities |
---|---|
M-CTPH-301 |
|
Mode of delivery
AA | Mode of delivery |
---|---|
M-CTPH-301 |
|
Required Reading
AA | Required Reading |
---|---|
M-CTPH-301 |
Required Learning Resources/Tools
AA | Required Learning Resources/Tools |
---|---|
M-CTPH-301 | Not applicable |
Recommended Reading
AA | Recommended Reading |
---|---|
M-CTPH-301 | Note de cours - CHIMIE ORGANIQUE APPLIQUEE AUX SCIENCES PHARMACEUTIQUE - François Dufrasne |
Recommended Learning Resources/Tools
AA | Recommended Learning Resources/Tools |
---|---|
M-CTPH-301 | Not applicable |
Other Recommended Reading
AA | Other Recommended Reading |
---|---|
M-CTPH-301 | * Chimie pharmaceutique de Graham L. Patrick; De Boeck; 2003 ISBN: 2744501549 * The practice of medicinal chemistry de C. G. Wermuth; Academic Press ; 2003; ISBN: 0127444815 * Chimie organique de Jonathan Clayden, Nick Greeves, Stuart Warren, Editions De Boeck; ISBN: 9782804174415 |
Grade Deferrals of AAs from one year to the next
AA | Grade Deferrals of AAs from one year to the next |
---|---|
M-CTPH-301 | Authorized |